SEC Form 3 · accession 0000899243-17-019239
TYME TECHNOLOGIES, INC. · TYME
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Giuseppe Del Priore
Officer — Chief Medical Officer
Period of report
Jul 27, 2017
Accepted (ET)
Jul 27, 2017 · 8:15 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001537917
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | holding | — | — | — | 2,582 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Employee Stock Option - right to buyF1 | $8.75 | holding | — | — | — | — | May 9, 2026 | Common Stock | 500,000 | — | D |
| Employee Stock Option - right to buy | $3.75 | holding | — | — | — | Oct 21, 2016 | Oct 21, 2026 | Common Stock | 25,000 | — | D |
| Employee Stock Option - right to buy | $2.75 | holding | — | — | — | Feb 8, 2017 | Feb 8, 2027 | Common Stock | 25,000 | — | D |
Explanation of responses
- F1The option grant is subject to a four-year vesting schedule, vesting 1/48 per month beginning on June 9, 2016